16-18
Jun
2026
CPHI & PMEC China 2026
Shanghai New International Expo Center
W4C60
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
4D123

Hubei Lingsheng Pharmaceuticals Co., Ltd.

  • Company view
About Hubei Lingsheng Pharmaceuticals Co., Ltd.

Hubei Lingsheng Pharma  was established on December 29, 2010 and headquarter in Xiangyang, Hubei Province with an area of more than 230 mu. We are a professional pharmaceutical enterprise, covering R&D, production, distribution and technical services of a whole industry chain for oral cephalosporin antibiotics, include Key intermediates, APIs and Preparations. such as 7-AVCA, 7-APRA, 7-ATCA, 7-AMCA, 7-ANCA, 7-ANCE, 7-ACCA, BCN, BT, BAPA, CHS, 3-OH and Cefditoren Pivoxil, Cefcapene Pivoxil Hydrochloride, Cefpodoxime proxetil, Ceftibuten.,etc.

Meet us at

  • CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    500 - 999
Company types
Pharmaceutical company
Contact info
  • Xiangcheng Economic Development Zone, Xiangyang , Hubei, China

Products from Hubei Lingsheng Pharmaceuticals Co., Ltd. (5)

  • 7-ACCA

    Product 7-ACCA

    头孢克洛母核(Intermediate of Cefaclor)

  • Cefpodoxime Proxetil

    Product Cefpodoxime Proxetil

    Cefpodoxime Proxetil
  • Cefixime trihydrate

    Product Cefixime trihydrate

    Cefixime trihydrate

  • Ceftibuten Dhydrate

    Product Ceftibuten Dhydrate

    产品名称(Product name):头孢布烯Ceftibuten Dhydrate

  • 7-AVCA

    Product 7-AVCA

    产品名称(Product name):7-AVCA
    头孢克肟、头孢地尼母核(Intermediate of Cefixime&Cefdinir)